BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 36029121)

  • 1. Impact of human leukocyte antigen mismatch on outcomes after unrelated bone marrow transplantation in paediatric patients: A retrospective analysis by the JSTCT HLA working group.
    Kato I; Sakaguchi H; Kato S; Sato M; Noguchi M; Yoshida N; Koh K; Koike T; Yanagimachi M; Kato K; Takahashi Y; Fujita N; Sato A; Hashii Y; Tabuchi K; Atsuta Y; Morishima S; Kanda J
    Br J Haematol; 2022 Nov; 199(3):392-400. PubMed ID: 36029121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of a single human leucocyte antigen (HLA) allele mismatch on the outcome of unrelated bone marrow transplantation over two time periods. A retrospective analysis of 3003 patients from the HLA Working Group of the Japan Society for Blood and Marrow Transplantation.
    Kanda Y; Kanda J; Atsuta Y; Maeda Y; Ichinohe T; Ohashi K; Fukuda T; Miyamura K; Iida H; Mori T; Iwato K; Eto T; Kawa K; Morita S; Morishima Y
    Br J Haematol; 2013 May; 161(4):566-77. PubMed ID: 23452319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological significance of HLA locus matching in unrelated donor bone marrow transplantation.
    Morishima Y; Kashiwase K; Matsuo K; Azuma F; Morishima S; Onizuka M; Yabe T; Murata M; Doki N; Eto T; Mori T; Miyamura K; Sao H; Ichinohe T; Saji H; Kato S; Atsuta Y; Kawa K; Kodera Y; Sasazuki T;
    Blood; 2015 Feb; 125(7):1189-97. PubMed ID: 25519752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Human Leukocyte Antigen Allele Mismatch in Unrelated Bone Marrow Transplantation with Reduced-Intensity Conditioning Regimen.
    Yokoyama H; Kanda J; Fuji S; Kim SW; Fukuda T; Najima Y; Ohno H; Uchida N; Ueda Y; Eto T; Iwato K; Kobayashi H; Ozawa Y; Kondo T; Ichinohe T; Atsuta Y; Kanda Y;
    Biol Blood Marrow Transplant; 2017 Feb; 23(2):300-309. PubMed ID: 27845190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome.
    Flomenberg N; Baxter-Lowe LA; Confer D; Fernandez-Vina M; Filipovich A; Horowitz M; Hurley C; Kollman C; Anasetti C; Noreen H; Begovich A; Hildebrand W; Petersdorf E; Schmeckpeper B; Setterholm M; Trachtenberg E; Williams T; Yunis E; Weisdorf D
    Blood; 2004 Oct; 104(7):1923-30. PubMed ID: 15191952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of KIR ligand incompatibility on the outcome of unrelated donor transplantation: a report from the center for international blood and marrow transplant research, the European blood and marrow transplant registry, and the Dutch registry.
    Farag SS; Bacigalupo A; Eapen M; Hurley C; Dupont B; Caligiuri MA; Boudreau C; Nelson G; Oudshoorn M; van Rood J; Velardi A; Maiers M; Setterholm M; Confer D; Posch PE; Anasetti C; Kamani N; Miller JS; Weisdorf D; Davies SM;
    Biol Blood Marrow Transplant; 2006 Aug; 12(8):876-84. PubMed ID: 16864058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Related transplantation with HLA-1 Ag mismatch in the GVH direction and HLA-8/8 allele-matched unrelated transplantation: a nationwide retrospective study.
    Kanda J; Saji H; Fukuda T; Kobayashi T; Miyamura K; Eto T; Kurokawa M; Kanamori H; Mori T; Hidaka M; Iwato K; Yoshida T; Sakamaki H; Tanaka J; Kawa K; Morishima Y; Suzuki R; Atsuta Y; Kanda Y
    Blood; 2012 Mar; 119(10):2409-16. PubMed ID: 22042692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors.
    Morishima Y; Sasazuki T; Inoko H; Juji T; Akaza T; Yamamoto K; Ishikawa Y; Kato S; Sao H; Sakamaki H; Kawa K; Hamajima N; Asano S; Kodera Y
    Blood; 2002 Jun; 99(11):4200-6. PubMed ID: 12010826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparable outcome after single-antigen-mismatched versus matched unrelated donor haematopoietic cell transplantation.
    Rockstroh A; Al-Ali HK; Lange T; Pönisch W; Krahl R; Cross M; Behre G; Niederwieser D; Pfrepper C
    J Cancer Res Clin Oncol; 2015 Dec; 141(12):2193-203. PubMed ID: 26129640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysis.
    Barker JN; Davies SM; DeFor T; Ramsay NK; Weisdorf DJ; Wagner JE
    Blood; 2001 May; 97(10):2957-61. PubMed ID: 11342417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-C antigen mismatch is associated with worse outcome in unrelated donor peripheral blood stem cell transplantation.
    Woolfrey A; Klein JP; Haagenson M; Spellman S; Petersdorf E; Oudshoorn M; Gajewski J; Hale GA; Horan J; Battiwalla M; Marino SR; Setterholm M; Ringden O; Hurley C; Flomenberg N; Anasetti C; Fernandez-Vina M; Lee SJ
    Biol Blood Marrow Transplant; 2011 Jun; 17(6):885-92. PubMed ID: 20870028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The impact of HLA high resolution typing mismatching of donor-recipient pairs on outcome of unrelated donor hematopoietic stem cell transplantation].
    He J; Xu C; Wu XJ; Bao XJ; Qiu QC; Yuan XN; Li Y; Shen HJ; Wu DP; Hong JL; Liu JH; DU HY; Zhang L; DU D; Lu J; Liu J
    Zhonghua Xue Ye Xue Za Zhi; 2012 May; 33(5):353-7. PubMed ID: 22781790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Equivalent outcomes in patients with chronic myelogenous leukemia after early transplantation of phenotypically matched bone marrow from related or unrelated donors.
    Davies SM; DeFor TE; McGlave PB; Miller JS; Verfaillie CM; Wagner JE; Weisdorf DJ
    Am J Med; 2001 Apr; 110(5):339-46. PubMed ID: 11286947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Case for High Resolution Extended 6-Loci HLA Typing for Identifying Related Donors in the Indian Subcontinent.
    Agarwal RK; Kumari A; Sedai A; Parmar L; Dhanya R; Faulkner L
    Biol Blood Marrow Transplant; 2017 Sep; 23(9):1592-1596. PubMed ID: 28603069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Superior survival associated with transplantation of matched unrelated versus one-antigen-mismatched unrelated or highly human leukocyte antigen-disparate haploidentical family donor marrow grafts for the treatment of hematologic malignancies: establishing a treatment algorithm for recipients of alternative donor grafts.
    Drobyski WR; Klein J; Flomenberg N; Pietryga D; Vesole DH; Margolis DA; Keever-Taylor CA
    Blood; 2002 Feb; 99(3):806-14. PubMed ID: 11806980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epitope Mismatch at HLA-DRB1 Associates with Reduced Relapse Risk in Cord Blood Transplantation for Standard-Risk Hematologic Malignancy.
    Morita-Fujita M; Shindo T; Iemura T; Arai Y; Kanda J; Okada K; Ueda Y; Yoshiyuki O; Anzai N; Mori T; Ishikawa T; Otsuka Y; Yonezawa A; Yuhi N; Imada K; Oba A; Itoh M; Okamoto Y; Kitano T; Ikeda T; Kotani S; Akasaka T; Yago K; Watanabe M; Nohgawa M; Tsuji M; Takeoka T; Yamamoto R; Arima N; Yoshinaga N; Hishizawa M; Yamashita K; Kondo T; Takaori-Kondo A;
    Transplant Cell Ther; 2023 Jun; 29(6):347.e1-347.e11. PubMed ID: 36889508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of HLA mismatch direction on the outcome of unrelated bone marrow transplantation: a retrospective analysis from the Japan Society for Hematopoietic Cell Transplantation.
    Kanda J; Ichinohe T; Fuji S; Maeda Y; Ohashi K; Fukuda T; Miyamura K; Iwato K; Eto T; Nakamae H; Kobayashi N; Mori T; Mori S; Morishima Y; Atsuta Y; Kanda Y;
    Biol Blood Marrow Transplant; 2015 Feb; 21(2):305-11. PubMed ID: 25464119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No effect of HLA-C mismatch after allogeneic hematopoietic stem cell transplantation with unrelated donors and T-cell depletion in patients with hematological malignancies.
    Magalhaes I; Uhlin M; Schaffer M; Sundin M; Hauzenberger D; Remberger M; Mattsson J
    Clin Transplant; 2017 Aug; 31(8):. PubMed ID: 28510343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation.
    Pidala J; Lee SJ; Ahn KW; Spellman S; Wang HL; Aljurf M; Askar M; Dehn J; Fernandez Viña M; Gratwohl A; Gupta V; Hanna R; Horowitz MM; Hurley CK; Inamoto Y; Kassim AA; Nishihori T; Mueller C; Oudshoorn M; Petersdorf EW; Prasad V; Robinson J; Saber W; Schultz KR; Shaw B; Storek J; Wood WA; Woolfrey AE; Anasetti C
    Blood; 2014 Oct; 124(16):2596-606. PubMed ID: 25161269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tacrolimus does not abrogate the increased risk of acute graft-versus-host disease after unrelated-donor marrow transplantation with allelic mismatching at HLA-DRB1 and HLA-DQB1.
    Przepiorka D; Saliba R; Cleary K; Fischer H; Tonai R; Fritsche H; Khouri IF; Folloder J; Ueno NT; Mehra R; Ippoliti C; Giralt S; Gajewski J; Donato M; Claxton D; Braunschweig I; van Besien K; Anderlini P; Andersson BS; Champlin R
    Biol Blood Marrow Transplant; 2000; 6(2A):190-7. PubMed ID: 10816027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.